No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anaplastic Lymphoma Kinase
-
Child, Preschool
-
Combined Modality Therapy
-
Crizotinib
-
Drug Resistance, Neoplasm* / drug effects
-
Drug Resistance, Neoplasm* / genetics
-
Female
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / genetics*
-
Leukemia, Myeloid, Acute / pathology
-
Leukemia, Myeloid, Acute / therapy*
-
Oncogene Proteins, Fusion / genetics*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrazoles / therapeutic use*
-
Pyridines / therapeutic use*
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
-
Receptor Protein-Tyrosine Kinases / genetics
-
Remission Induction
-
Transplantation, Homologous
Substances
-
Oncogene Proteins, Fusion
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyridines
-
RANBP2-ALK fusion protein, human
-
Crizotinib
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases